Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › carbidopa

carbidopa

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of carbidopa

9 trials tracked of carbidopa: 5 in phase 3 or 4.

9Trials tracked
5Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 4 Phase 2 2 Phase 1 2
  1. Phase 4 Norepinephrine-targeted Therapy for Action Control in Parkinson Disease Completed
  2. Phase 3 Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia Completed
  3. Phase 3 Peripheral Dopamine in Postural Tachycardia Syndrome Completed
  4. Phase 3 Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon Completed
  5. Phase 3 Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. Completed
  6. Phase 2 Neurobiological Drivers of Mobility Resilience: The Dopaminergic System Completed
Show 3 more trials
  1. Phase 2 High and Low Dose Carbidopa Treatment of Parkinson's Disease Completed
  2. Phase 1 Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550) Completed
  3. Phase 1 Dose-finding Pharmacokinetic Study in Healthy Males Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Continuous subcutaneous foslevodopa/foscarbidopa improves off time in Parkinson's disease; severe adverse events higher in prior DBS group
Neurology Phase III
Continuous subcutaneous foslevodopa/foscarbidopa improves off time in Parkinson's disease; severe adverse events higher in prior DBS group Patients with Parkinsons disease who had prior brain surgery saw more side effects while using new skin patches
This post hoc analysis of an open-label phase 3 trial evaluated continuous subcutaneous infusion of foslevodopa/foscarbidopa in 244 patients…
A new look at trial data shows skin patches help Parkinsons patients move better and sleep longer. However, those who had brain surgery earl…
Jun 1, 2026